In the lymphoid cell compartment of patients with early MS, using antibody Panel A, we detected increased frequencies of CD4+ and CD8+ cells that highly expressed CCR7 and were negative for CD95 (Fas). The gene discussed is CCR7; the disease is myeloid sarcoma.